1-6 of 6
Authors: Kenneth Usuki
Journal Article
BIOM-03. LACK OF CORRELATION OF MR-DETERMINED WHITE MATTER INJURY(WMI)WITH NEUROCOGNITIVE FUNCTION (NCF)6 MONTHS FOLLOWING WBRT+/-HIPPOCAMPAL AVOIDANCE(HA)+MEMANTINE:SECONDARY ANALYSIS OF NRG ONCOLOGY NRGCC001
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v4, https://doi.org/10.1093/neuonc/noad179.0014
Published: 10 November 2023
Journal Article
RADT-01. BASELINE HIPPOCAMPAL VOLUME AS A PREDICTOR OF NEUROCOGNITIVE CHANGES AFTER WBRT OR HA-WBRT: SECONDARY ANALYSIS OF NRG ONCOLOGY CC001
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v48, https://doi.org/10.1093/neuonc/noad179.0190
Published: 10 November 2023
Journal Article
NCOG-03. IMPACT OF THE RATE OF RADIOGRAPHIC RESPONSE (RR) OF BRAIN METASTASES (BM) TO WHOLE BRAIN RADIATION THERAPY (WBRT) ON NEUROCOGNITIVE FUNCTION (NCF) ON NRG-CC001
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii197, https://doi.org/10.1093/neuonc/noac209.756
Published: 14 November 2022
Journal Article
ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi24–vi25, https://doi.org/10.1093/neuonc/noz175.092
Published: 11 November 2019
Journal Article
NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi172, https://doi.org/10.1093/neuonc/noy148.716
Published: 05 November 2018
Journal Article
HCP-16POPULATION-BASED SURVIVAL RATES FROM HIGH GRADE GLIOMA (HGG) ARE NOT IMPROVED BY INCREASED CHEMOTHERAPY USE
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v104–v105, https://doi.org/10.1093/neuonc/nov216.16
Published: 09 November 2015
